211 related articles for article (PubMed ID: 26112215)
1. Endostatin induces proliferation of oral carcinoma cells but its effect on invasion is modified by the tumor microenvironment.
Alahuhta I; Aikio M; Väyrynen O; Nurmenniemi S; Suojanen J; Teppo S; Pihlajaniemi T; Heljasvaara R; Salo T; Nyberg P
Exp Cell Res; 2015 Aug; 336(1):130-40. PubMed ID: 26112215
[TBL] [Abstract][Full Text] [Related]
2. Arresten, a collagen-derived angiogenesis inhibitor, suppresses invasion of squamous cell carcinoma.
Aikio M; Alahuhta I; Nurmenniemi S; Suojanen J; Palovuori R; Teppo S; Sorsa T; López-Otín C; Pihlajaniemi T; Salo T; Heljasvaara R; Nyberg P
PLoS One; 2012; 7(12):e51044. PubMed ID: 23227231
[TBL] [Abstract][Full Text] [Related]
3. The hypoxic tumor microenvironment regulates invasion of aggressive oral carcinoma cells.
Teppo S; Sundquist E; Vered M; Holappa H; Parkkisenniemi J; Rinaldi T; Lehenkari P; Grenman R; Dayan D; Risteli J; Salo T; Nyberg P
Exp Cell Res; 2013 Feb; 319(4):376-89. PubMed ID: 23262025
[TBL] [Abstract][Full Text] [Related]
4. Endostatin inhibits migration and invasion of head and neck squamous cell carcinoma cells.
Wilson RF; Morse MA; Pei P; Renner RJ; Schuller DE; Robertson FM; Mallery SR
Anticancer Res; 2003; 23(2B):1289-95. PubMed ID: 12820385
[TBL] [Abstract][Full Text] [Related]
5. Endostatin inhibits the tumorigenesis of hemangioendothelioma via downregulation of CXCL1.
Guo L; Song N; He T; Qi F; Zheng S; Xu XG; Fu Y; Chen HD; Luo Y
Mol Carcinog; 2015 Nov; 54(11):1340-53. PubMed ID: 25175281
[TBL] [Abstract][Full Text] [Related]
6. Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects.
Abdollahi A; Lipson KE; Sckell A; Zieher H; Klenke F; Poerschke D; Roth A; Han X; Krix M; Bischof M; Hahnfeldt P; Grone HJ; Debus J; Hlatky L; Huber PE
Cancer Res; 2003 Dec; 63(24):8890-8. PubMed ID: 14695206
[TBL] [Abstract][Full Text] [Related]
7. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
[TBL] [Abstract][Full Text] [Related]
8. Anti-endostatin monoclonal antibody enhances growth of human hepatocellular carcinoma cells by inhibiting activity of endostatin secreted by the transplanted cells in nude mice.
Tsuboi S; Nouso K; Tomono Y; Nagamori S; Naito I; Watanabe T; Manabe K; Ohmori H; Nakatsukasa H; Miyazaki M; Higashi T; Shiratori Y; Namba M; Ninomiya Y
Int J Oncol; 2004 Nov; 25(5):1267-71. PubMed ID: 15492814
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition of tongue cancer development in nude mice transfected with adenovirus carrying human endostatin gene].
Ding XQ; Chen Y; Li L; Liu RY; Huang JL; Lai K; Wu XJ; Ke ML; Huang WL
Ai Zheng; 2003 Nov; 22(11):1152-7. PubMed ID: 14613642
[TBL] [Abstract][Full Text] [Related]
10. The anti-angiogenic activity of human endostatin inhibits bladder cancer growth and its mechanism.
Du Z; Hou S
J Urol; 2003 Nov; 170(5):2000-3. PubMed ID: 14532841
[TBL] [Abstract][Full Text] [Related]
11. Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13.
Nyberg P; Heikkilä P; Sorsa T; Luostarinen J; Heljasvaara R; Stenman UH; Pihlajaniemi T; Salo T
J Biol Chem; 2003 Jun; 278(25):22404-11. PubMed ID: 12690120
[TBL] [Abstract][Full Text] [Related]
12. Intravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cells.
Read TA; Farhadi M; Bjerkvig R; Olsen BR; Rokstad AM; Huszthy PC; Vajkoczy P
Cancer Res; 2001 Sep; 61(18):6830-7. PubMed ID: 11559558
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy.
Li M; Ye C; Feng C; Riedel F; Liu X; Zeng Q; Grandis JR
Clin Cancer Res; 2002 Nov; 8(11):3570-8. PubMed ID: 12429648
[TBL] [Abstract][Full Text] [Related]
14. Endostatin and anastellin inhibit distinct aspects of the angiogenic process.
Neskey DM; Ambesi A; Pumiglia KM; McKeown-Longo PJ
J Exp Clin Cancer Res; 2008 Nov; 27(1):61. PubMed ID: 18983664
[TBL] [Abstract][Full Text] [Related]
15. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
16. A novel organotypic model mimics the tumor microenvironment.
Nurmenniemi S; Sinikumpu T; Alahuhta I; Salo S; Sutinen M; Santala M; Risteli J; Nyberg P; Salo T
Am J Pathol; 2009 Sep; 175(3):1281-91. PubMed ID: 19679876
[TBL] [Abstract][Full Text] [Related]
17. [The inhibitory effect of human endostatin gene on tumor growth of tongue squamous cell carcinoma].
Pan CB; Huang HZ; Wang JG; Hou JS; Li HG
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Jul; 39(4):273-6. PubMed ID: 15454007
[TBL] [Abstract][Full Text] [Related]
18. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
[TBL] [Abstract][Full Text] [Related]
19. Neoplastic extracellular matrix environment promotes cancer invasion in vitro.
Sundquist E; Renko O; Salo S; Magga J; Cervigne NK; Nyberg P; Risteli J; Sormunen R; Vuolteenaho O; Zandonadi F; Paes Leme AF; Coletta RD; Ruskoaho H; Salo T
Exp Cell Res; 2016 Jun; 344(2):229-40. PubMed ID: 27090016
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic targeting of angiogenesis with a recombinant CTT peptide-endostatin mimic-kringle 5 protein.
Wang H; Yang Z; Gu J
Mol Cancer Ther; 2014 Nov; 13(11):2674-87. PubMed ID: 25127900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
